5-hydroxymethylcytosine has been researched along with Multiple System Atrophy Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aznar, S; Blaabjerg, M; Bode, M; Brudek, T; Busato, F; Chauhan, AS; Danielsen, EH; Folke, J; Hejl, AM; Løkkegaard, A; Møller, M; Pakkenberg, B; Roché, E; Rydbirk, R; Tost, J | 1 |
| Kaut, O; Kuchelmeister, K; Moehl, C; Wüllner, U | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Brain; Case-Control Studies; DNA Methylation; Epigenesis, Genetic; Epigenome; Female; Flow Cytometry; HLA Antigens; Humans; Killer Cells, Natural; Leukocytes, Mononuclear; Male; Middle Aged; Monocytes; Multiple System Atrophy; Prefrontal Cortex; T-Lymphocytes; Transcriptome; Ubiquitin-Protein Ligases | 2020 |
5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Brain; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease | 2019 |